Michael Bosco
Pharmacist
259 1st St, Mineola
New York, 11501-3957
516-663-9178 Michael Bosco is a pharmacist in Mineola, New York. Patients can reach him at 259 1st St, Mineola or contact him on 516-663-9178. Active license number of Michael Bosco is 062914 for Pharmacist in New York.
Michael Bosco is
Complete Profile:
Michael Bosco speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Michael Bosco |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | Male |
| Location: | 259 1st St, Mineola,
New York, 11501-3957 |
| Phone: | 516-663-9178 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Michael Bosco are as mentioned below.
| NPI Number: | 1295561454 |
| NPI Enumeration Date: | 12 Sep, 2024 |
| NPI Last Update On: | 12 Sep, 2024 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael Bosco are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | 062914 | New York | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 259 1st St Dept Of,
Mineola, New York |
| Zip: | 11501-3957 |
| Phone Number: | 516-663-9178 |
Patients can reach Michael Bosco at
259 1st St, Mineola, New York or can
call on phone at 516-663-9178.
Comments/ Reviews:
Read all the reviews posted for Michael Bosco below. You may also share your own experience with Michael Bosco. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.